Norris Medicines Limited shareholders approved all six resolutions proposed at the company's 35th Annual General Meeting (AGM) held on September 29, 2026. The meeting, conducted via video conferencing, saw significant voting support for key corporate actions, including the reappointment of the Managing Director and enhancements to borrowing limits.

The scrutinizer's report confirmed that every resolution passed with the requisite majority. Voting rights were reckoned as of September 22, 2026. The meeting was held in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013, utilizing remote e-voting facilities provided by Purva Sharegistry India Pvt. Ltd.

Key resolutions passed

The ordinary business items included the adoption of audited financial statements for FY26 and the reappointment of Mr. Praveen J. Bafna as a director retiring by rotation. Both items received overwhelming support from both promoter and public shareholders.

Special business items focused on governance and financial flexibility. These included the appointment of Mr. Vimal D. Shah as Managing Director, an increase in borrowing limits, authorization for the disposal of undertaking, and enhancement of investment limits under Section 186 of the Companies Act, 2013.

What the numbers show

A distinct pattern emerged in the voting data for the special resolution regarding Mr. Vimal D. Shah's appointment. While promoters voted in favor, their votes were classified as "invalid" for the purpose of determining the result because Mr. Shah is an interested party. Consequently, the resolution passed based solely on public shareholder votes, which constituted 43,52,529 votes in favor against 27,660 votes against. This highlights a governance structure where promoter influence is legally restricted in self-dealing matters, yet public shareholder consensus remained strong at 99.37% support among valid votes.

Voting results summary

The following table summarizes the voting outcomes for the six resolutions passed at the AGM:

Note: Percentages are calculated based on valid votes cast. Invalid votes are excluded from the favor/against calculation.

The high consistency in voting patterns across five of the six resolutions suggests aligned shareholder interests regarding the company's operational and financial strategy. The only deviation occurred in the Managing Director appointment, where regulatory requirements mandated the exclusion of interested party votes.

Norris Medicines will hold its 35th Annual General Meeting on Tuesday, September 29, 2026, through Video Conferencing or Other Audio-Visual Means. The meeting is scheduled for 2:30 pm IST.

The company announced the intimation pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Director Vimal D. Shah signed the notice dated September 4, 2026.

Key Dates

The register of members and share transfer books remain closed from Wednesday, September 23, 2026, through the meeting date. Only shareholders registered as of the record date are eligible to participate.

E-Voting Details

Remote e-voting begins on Saturday, September 26, 2026, at 9:00 am and ends on Monday, September 28, 2026, at 5:00 pm. Parva Sharegistry (India) Private Limited facilitates the electronic voting system. The cut-off date for determining voting eligibility is Tuesday, September 22, 2026.

Members holding shares in physical or dematerialized form as on the cut-off date may cast votes electronically. Once a vote is cast remotely, it cannot be changed. Members who vote remotely may attend the AGM but cannot vote again during the meeting.

Meeting Logistics

Electronic copies of the AGM notice and the annual report for FY26 have been sent to members with registered email IDs. Physical letters containing web links were couriered to others. The dispatch was completed on Friday, September 4, 2026.

Mr. Hemant Shetye, Partner at HSPN & Associates LLP, has been appointed as the scrutinizer for the e-voting process. The facility for proxy appointment is not available for this VC/OAVM meeting.